ADR,SEQ,PT,HLT,HLGT,SOC_ABBREV,FATAL_YN
1,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1,2,Heart rate increased,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
1,3,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
1,4,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
2,1,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
3,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
3,2,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
4,1,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
4,2,Vascular skin disorder,Skin vascular conditions NEC,Skin vascular abnormalities,Skin,N
5,1,Blood creatine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
6,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
6,2,Joint swelling,Joint related signs and symptoms,Joint disorders,Musc,N
7,1,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
8,1,Blood alkaline phosphatase increased,Tissue enzyme analyses NEC,Enzyme investigations NEC,Inv,N
8,2,Blood urea increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
8,3,Catheter site infection,Infections NEC,Infections - pathogen unspecified,Infec,N
9,1,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
10,1,Headache,Headaches NEC,Headaches,Nerv,N
10,2,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
11,1,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,Y
12,1,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
13,1,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
14,1,Gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
15,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
15,2,Yawning,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
16,1,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
16,2,Headache,Headaches NEC,Headaches,Nerv,N
16,3,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
17,1,C-reactive protein increased,Protein analyses NEC,Protein and chemistry analyses NEC,Inv,N
17,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
17,3,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
17,4,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
17,5,Pain of skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
17,6,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
17,7,Platelet count increased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
17,8,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
17,9,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
17,10,White blood cell count increased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
18,1,Diabetic retinal oedema,"Retinal, choroid and vitreous infections and inflammations","Ocular infections, irritations and inflammations",Eye,N
19,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
20,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
21,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
